USPTO serial 79294659
CONGENICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 24, 2021
- Examiner
- WITKOWSKI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CONGENICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for database management, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer platform software for database management, genome sequencing, annotation, disease prediction interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer database software for database management, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer software for data analysis and reporting; downloadable computer software for genome sequencing, annotation, disease prediction, interpretation and reporting; downloadable computer software for potential patient identification and medical diagnosis; downloadable computer software for drug discovery and research; downloadable computer software for research and medical purposes; electronic computer databases in the fields of life sciences, medicine, healthcare, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments and drug development, discovery and research, treatment of disease recorded on computer media; computer database servers; downloadable computer software for database management; downloadable computer software for creating searchable databases of information and data; downloadable electronic publications in the nature of white papers, articles, magazines and brochures in the field of life sciences, medicine and healthcare downloadable from the Internet | ACTIVE | — |
| 035 | Database management; computer database management; database management and database management services in the nature of reporting services information and details from the database; computerised database management services; data management services, namely, collecting and managing data relating to genome sequencing, disease prediction, medical diagnosis and drug development, discovery and treatment; data processing management; compilation of data and information in computer databases; data processing and analysis services; information, advisory and consultancy services in relation to all of the aforesaid | ACTIVE | — |
| 038 | Providing access to computer databases; arranging access to computer databases in the nature of providing access to the databases; operation of computer networks for accessing and sharing data, namely, transmission and distribution of data via a global computer network; information, advisory and consultancy services in relation to all of the aforesaid | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of inherited and acquired genetic disorders, common disorders and disease; scientific research and development services; design and development of databases; design and development of computer databases; database design and development services; computer database design and development services; research and development in the field of genomics; laboratory analysis, namely, genome interpretation and DNA sequencing services; software as a service services featuring software for interpreting inherited and acquired genetic disorders, common disorders and disease; providing software as a service services featuring software for genome sequencing, annotation, interpretation and reporting; providing computer software platforms as a service featuring software for genome sequencing, annotation, interpretation and reporting; providing software as a service featuring software for drug discovery and research; providing software as a service featuring software for potential patient identification and medical diagnosis; providing software as a service featuring software for research and medical purposes; installation, updating and maintenance of computer software; information, advisory and consultancy services in relation to all of the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Congenica Ltd
- Other trademarks owned by Congenica Ltd
- Other trademarks owned by Congenica Ltd
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named CONGENICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 29, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 29, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 28, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 3, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 24, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 24, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 5, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 2, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 2, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 9, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |